'Novel Therapeutic Targets in Juvenile Myelomonocytic Leukemia: Are noncoding RNAs Valuable Treatment Options?' - PhD defence

Mattias Hofmans is defending his doctoral thesis entitled 'Novel Therapeutic Targets in Juvenile Myelomonocytic Leukemia: Are noncoding RNAs Valuable Treatment Options?'.